摘要
2019年12月,中国武汉暴发新型冠状病毒肺炎(COVID-19),该疾病传染性强,迅速在国内外传播,引起了高度关注。临床尚无确切有效的抗病毒治疗药物。鉴于目前疫情的紧迫性,根据推荐的诊疗方案和相关研究,本文对瑞德西韦、奥司他韦、阿比多尔、洛匹那韦/利托那韦、利巴韦林及干扰素α等试用于临床的抗病毒药物进行介绍,以期能为COVID-19的药物合理选择提供参考。
In December 2019,the endemic of COVID-19 broke out in Wuhan,China.The disease is highly contagious and quickly spreads at home and abroad,causing great concern.However,there are no definite effective antiviral drugs in clinical use.Given the urgency of the COVID-19 outbreak,based on the diagnosis and treatment recommendation and relavant researches,this article describes the optional antiviral drugs such as remdesivir,oseltamivir,arbidol,lopinavir/ritonavir,ribavirin,and interferon-αto provide a reference for treatment of COVID-19.
作者
肖婷婷
杨凯
黄晨
朱云颖
吴珍珠
肖永红
Xiao Tingting;Yang Kai;Huang Chen;Zhu Yunying;Wu Zhenzhu;Xiao Yonghong(State Key Laboratory for Diagnosis and Treatment of Infectious Diseases,National Clinical Research Center for Infectious Diseases,Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases,the First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310003,China;Department of Pulmonary and Critical Care Medicine,Lihuili Hospital,Ningbo Medical Center,Ningbo 315041,China;Department of Infectious Diseases,the Second Affiliated Hospital and Yuying Children’Hospital of Wenzhou Medical University,Wenzhou 325027,China)
出处
《中华临床感染病杂志》
CSCD
2020年第2期92-101,共10页
Chinese Journal of Clinical Infectious Diseases
基金
国家重点研发计划(2017YFC200203)
浙江省重点研发计划(2015C03032)。
